Methamphetamine use and risky sexual behaviors during heterosexual encounters

Sexually Transmitted Diseases

Volumn 34, Issue 9, 2007, Pages 689-694

  Zule, William A ^a   Costenbader, Elizabeth C ^a   Meyer, William J ^a   Wechsberg, Wendee M ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE;

ADULT; ANUS INTERCOURSE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG USE; FEMALE; HETEROSEXUALITY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ORAL SEXUAL CONTACT; PROTECTIVE EQUIPMENT; RISK FACTOR; SEXUAL BEHAVIOR; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADULT; AGE DISTRIBUTION; AMPHETAMINE-RELATED DISORDERS; ETHNIC GROUPS; FEMALE; HETEROSEXUALITY; HUMANS; MALE; NORTH CAROLINA; QUESTIONNAIRES; RISK-TAKING; SEX DISTRIBUTION; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SOCIOECONOMIC FACTORS;

EID: 34548188315     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000260949.35304.22     Document Type: Article

References (31)

1. Paul JP, Stall R, Davis F. Sexual risk for HIV transmission among gay/bisexual men in substance-abuse treatment. AIDS Educ Prev 1993; 5:11-24.
2. Frosch D, Shoptaw S, Huber A, et al. Sexual HIV risk among gay and bisexual male methamphetamine abusers. J Subst Abuse Treat 1996; 13:483-486.
3. Gorman EM, Barr BD, Hansen A, et al. Speed, sex, gay men, and HIV: Ecological and community perspectives. Med Anthropol Q 1997; 11:505-515.
4. Reback, CJ. The social construction of a gay drug: Methamphetamine use among gay and bisexual males in Los Angeles. City of Los Angeles, LA: AIDS Coordinator. 1997.
5. Reback CJ, Larkins S, Shoptaw S. Changes in the meaning of sexual risk behaviors among gay and bisexual male methamphetamine abusers before and after drug treatment. AIDS Behav 2004; 8:87-98.
6. Lambert E, Normand J, Stall R, et al. Introduction: New dynamics of HIV risk among drug-using men who have sex with men. J Urban Health 2005; 82:i1-i8.
7. Halkitis PN, Shrem MT. Psychological differences between binge and chronic methamphetamine using gay and bisexual men. Addict Behav 2006; 31:549-552.
8. Hando J, Hall W. HIV risk-taking behaviour among amphetamine users in Sydney, Australia. Addiction 1994; 89:79-85.
9. Molitor F, Truax SR, Ruiz JD, et al. Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West J Med 1998; 168:93-97.
10. Zule WA, Desmond DP. An ethnographic comparison of HIV risk behaviors among heroin and methamphetamine injectors. Am J Drug Alcohol Abuse 1999; 25:1-23.
11. Gibson DR, Leamon MH, Flynn N. Epidemiology and public health consequences of methamphetamine use in California's Central Valley. J Psychoactive Drugs 2002; 34:313-319.
12. Rawson RA, Washton A, Domier CP, et al. Drugs and sexual effects: Role of drug type and gender. J Subst Abuse Treat 2002; 22:103-108.
13. Wohl AR, Johnson DF, Lu S, et al. HIV risk behaviors among African American men in Los Angeles County who self-identify as heterosexual. J Acquir Immune Defic Syndr 2002; 31:354-360.
14. Somlai AM, Kelly JA, McAuliffe TL, et al. Predictors of HIV sexual risk behaviors in a community sample of injection drug-using men and women. AIDS Behav 2003; 7:383-393.
15. Semple SJ, Grant I, Patterson TL. Female methamphetamine users: Social characteristics and sexual risk behavior. Women Health 2004; 40:35-50.
16. Semple SJ, Patterson TL, Grant I. The context of sexual risk behavior among heterosexual methamphetamine users. Addict Behav 2004; 29:807-810.
17. Semple SJ, Patterson TL, Grant I. Determinants of condom use stage of change among heterosexually-identified methamphetamine users. AIDS Behav 2004; 8:391-400.
18. Brown AH, Domier CP, Rawson RA. Stimulants, sex, and gender. Sexual Addiction & Compulsivity 2005; 2:169-180.
19. Centers for Disease Control and Prevention (CDC). Methamphetamine use and HIV risk behaviors among heterosexual men: Preliminary results from five northern California counties, December 2001-November 2003. MMWR Morb Mortal Wkly Rep 2006; 55:273-277.
20. Mansergh G, Shouse RL, Marks G, et al. Methamphetamine and sildenafil (Viagra) use are linked to unprotected receptive and insertive anal sex, respectively, in a sample of men who have sex with men. Sex Transm Infect 2006; 82:131-134.
21. Watters JK, Biernacki P. Targeted sampling: Options for the study of hidden populations. Soc Probl 1989; 36:416-430.
22. Carlson RG, Wang J, Siegal HA, et al. An ethnographic approach to targeted sampling: Problems and solutions in AIDS prevention research among injection drug and crack-cocaine users. Hum Organ 1994; 53:279-286.
23. Cunningham-Williams RM, Cottler LB, Compton WM, et al. Reaching and enrolling drug users for HIV prevention: A multi-site analysis. Drug Alcohol Depend 1999; 54:1-10.
24. Diggle PJ, Heagerty P, Ling K-Y, et al. Analysis of Longitudinal Data. 2nd ed. New York: Oxford, 2002.
25. Molitor F, Ruiz JD, Flynn N, et al. Methamphetamine use and sexual and injection risk behaviors among out-of-treatment injection drug users. Am J Drug Alcohol Abuse 1999; 25:475-493.
26. Tchoudomirova K, Mardh PA, Kallings I, et al. History, clinical findings, sexual behavior and hygiene habits in women with and without recurrent episodes of urinary symptoms. Acta Obstet Gynecol Scand 1998; 77:654-659.
27. Taha TE, Gray RH, Kumwenda NI, et al. HIV infection and disturbances of vaginal flora during pregnancy. J Acquir Immune Defic Syndr Hum Retrovirol 1999; 20:52-59.
28. Bukusi EA, Cohen CR, Meier AS, et al. Bacterial vaginosis: Risk factors among Kenyan women and their male partners. Sex Transm Dis 2006; 33:361-367.
29. Kall KI. Effects of amphetamine on sexual behavior of male IV drug users in Stockholm: A pilot study. AIDS Educ Prev 1992; 4:6-17.
30. Kall KI, Nilsonne A. Preference for sex on amphetamine: A marker for HIV risk behaviour among male intravenous amphetamine users in Stockholm. AIDS Care 1995; 7:171-188.
31. Macalino GE, Celentano DD, Latkin C, et al. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev 2002; 14:367-378.